VEGFA and Miyoshi myopathy: (73) originally observed higher IL-17A levels in the peripheral blood of MM patients of stage II and III compared to stage I and a positive correlation with VEGF and microvessel density in the BM, thus hypothesizing a proangiogenic role for IL-17A in MM.